Astrazenaca Covishield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SII seeks DCGI's permission to manufacture Sputnik V ANI 03 Jun 2021, 19:18 GMT+10 By Shalini BhardwajNew Delhi [India], June 3 (ANI): Indian vaccine manufacturing company Serum Institute of India (SII) has sought permission from the Drug Controller General of India (DCGI) for the production of the Russian vaccine Sputnik V in India. SII has applied for a test license to manufacture the COVID-19 vaccine. Currently, Dr Reddy's Lab is the Russian Direct Investment Fund (RDIF) partner, which markets the Sputnik V vaccine in India. RDIF and Dr Reddy's Laboratories had in a joint statement said , ...

New Delhi [India], June 3 (ANI): Indian vaccine manufacturing company Serum Institute of India (SII) has sought permission from the Drug Controller General of India (DCGI) for the production of the Russian vaccine Sputnik V in India.

While China's another 9 vaccines are only in the first or second phase of human trials, the data says another 17 vaccines from different parts of the world are in the final Phase III stage, which means these vaccines are likely to be available commercially in the coming months. Prominent among them are Zycov-D from India's Zydus Cadila which is expected to be launched in the coming months and Hyderabad-based manufacturer Biological E's BECOV2, which got final phase trial clearance from the Drug Controller General of India (DCGI) last week. Serum Institute, in partnership with US-based Novavax...